GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,469.00p
   
  • Change Today:
      7.00p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,293.50p
  • Currency: UK Pounds
  • Shares Issued: 4,127.91m
  • Volume: 8,622,227
  • Market Cap: £60,639m
  • RiskGrade: 129
  • Beta: 0.01

Other News

FTSE 100 preview: Greek delay hits shares 20-Jun-2011 This Is Money
GlaxoSmithKline gets green light over Potiga 14-Jun-2011 This Is Money

Irish zinc explorer Connemara Mining ...

11-Jun-2011 Proactive Investors
FTSE preview: Gloom over commodities 10-Jun-2011 This Is Money
FTSE preview: Shares hit by US jobs woe 06-Jun-2011 This Is Money
FTSE in-depth: Unilever up on £38bn bi... 01-Jun-2011 This Is Money
Newspaper and magazine share tips 24-May-2011 This Is Money
Midas: At last, Dogs are setting the pace 14-May-2011 This Is Money
How to enjoy the dividend revival 14-May-2011 This Is Money
Can you invest with a clear conscience? 10-May-2011 This Is Money
FTSE close: RBS, Capita up; miners rally 10-May-2011 This Is Money
FTSE 100 preview: US nerves knock shares 06-May-2011 This Is Money
FTSE preview: Shares to fall on profit-taking 04-May-2011 This Is Money
GlaxoSmithKline hit by cuts to spending 28-Apr-2011 This Is Money
FTSE preview: Shares wait on GDP & BP 27-Apr-2011 This Is Money
FTSE preview: Sluggish start after holiday 26-Apr-2011 This Is Money
City diary: Week ahead in the markets 21-Apr-2011 This Is Money
AstraZeneca to sell £1.3bn dental unit 17-Apr-2011 This Is Money
FTSE close: Next, Reckitt up; banks fall 15-Apr-2011 This Is Money
FTSE close: Banks, BP bounce; M&S, Dixon... 01-Apr-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,469.00p
Change Today 7.00p
% Change 0.48 %
52 Week High 1,812.50p
52 Week Low 1,293.50p
Volume 8,622,227
Shares Issued 4,127.91m
Market Cap £60,639m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.42% below the market average67.42% below the market average67.42% below the market average67.42% below the market average67.42% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
Price Trend
3.29% above the market average3.29% above the market average3.29% above the market average3.29% above the market average3.29% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income
62.55% above the market average62.55% above the market average62.55% above the market average62.55% above the market average62.55% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
47.36% below the market average47.36% below the market average47.36% below the market average47.36% below the market average47.36% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 01-Apr-2025

Time Volume / Share Price
16:20 0 @ 1,472.00p
16:00 1 @ 1,471.00p
16:00 1 @ 1,471.00p
16:00 1 @ 1,471.00p
16:05 0 @ 1,473.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page